Introduction
Growth factors play a major role in medical research as components of cell culture media used for proliferation and differentiation of various cells. Their use is expected to increase dramatically as progress is made in stem cell research, tissue engineering and regenerative medicine. Furthermore, their application as biopharmaceuticals for human therapeutic use is becoming increasingly important.
Recombinant growth factors are commercially produced in different host expression systems such as bacteria, yeast, insect and mammalian cells. While these systems can be efficient, there is still a need for new production systems that are serum-and animal-free, more economical, and void of endotoxins and other contaminating components, such as pyrogenic and pro-inflammatory agents that may affect their use in biological systems and assays. A number of different plant systems are in development for the efficient production of protein biopharmaceuticals such as growth factors (for review see [1] ). Barley seeds and other cereals are plant systems that have been explored with good results for molecular farming [2, 3] . Using barley seeds for heterologous protein production is an attractive option because they are a cost-saving alternative that are easy to grow and with wellestablished post-harvest handling and processing methods [4, 5] . The majority of human proteins that have been produced in plants show significant structural, biochemical and functional similarity to proteins from animal cell systems [6] . Furthermore, barley as a host system 4 features genetic self-containment, as barley is a self-pollinating crop plant. Barley is Generally Regarded As Safe (G.R.A.S.) by the FDA with low secondary metabolite content, such as phenolics (unpublished data). Presently, most plant produced biopharmaceuticals and other recombinant proteins have been expressed in tobacco which is known for the presence of alkaloids and other compounds potentially toxic to humans [7] . Accumulating heterologous proteins in seeds presents many advantages as seeds are natural long-term storage vehicles of proteins within an inert environment. They can be stored for years without affecting the quality of the protein [4, 8] and they have a relatively simple protein profile with the major part belonging to few and dominant polypeptide classes that can be separated with relative ease from the target protein, thus facilitating downstream procedures considerably [9] .
Flt3 ligand is an essential hematopoietic growth factor involved in proliferation and differentiation of stem cells and in the development of NK cells, B cells, T cells, monocytes/macrophages and dendritic cells. Flt3 ligand may be of clinical value as it is, together with other growth factors and cytokines, considered a stimulant of the immune system through its effect on both dendritic and natural killer cells production (reviewed by [10] ). Recombinant human Flt3 ligand is commercially available from bacterial source and CHO cells. In the present paper, we describe the production of recombinant human Flt3 ligand in barley grain using the Orfeus expression system developed 5 by ORF Genetics for production of recombinant proteins termed ISOkines.
To our knowledge, this is the first report describing expression and purification of a recombinant human growth factor from cereal seeds with biological activity comparable to commercially available counterparts. This is also the first publication on expression of Flt3 ligand in a plant system. The results demonstrate that barley is a proficient system for the production of active recombinant growth factors for cell culture, media preparation and medical application.
Methods and materials

Expression cassette
The cDNAs for human 
Barley transformation and selection of transformants
Purification of barley seed-expressed human Flt3 ligand
Second generation seeds (T 2 ) were harvested during the full ripeness using bovine serum albumin as standard.
Purified Flt3 ligand was prepared for biological activity measurement by buffer exchange using HiTrap desalting column (GE Healthcare).
The protein was eluted in 10 mM acetic acid pH 5.0 and subsequently freeze-dried.
Immunoblotting
Proteins were fractionated by SDS-PAGE [12] and transferred to a polyvinylideneflouride blotting membrane (Immobilon-P, Millipore, Boston, MA) using wet blot transfer (BioRad). Transfer buffer was 20 mM Tris, 150 mM glycine containing 20% (v/v) methanol. Rabbit antiserum against human Flt3 ligand (ABC509) was obtained from
Autogen-Bioclear, UK. Immunodetection was carried out by using 9 horseradish peroxidase labeled secondary antibody and 3,3´,5,5´-tetramethylbenzidine stabilized substrate for colorometric analysis.
Proteolytic digestion and mass spectrometry
For quality analyses, the recombinant product was loaded and run on SDS-PAGE, followed by Coomassie staining. Relevant band(s) were excised and treated for in-gel digestion, essentially as described [13] .
Briefly, the stain was removed and the gel band was dried using neat acetonitrile. Trypsin (modified, sequence grade porcine from Promega The generated peptide mass list was used to search for identity with known proteins in the NCBInr database, using the search engine ProFound (http://prowl.rockefeller.edu/prowl-cg). Alternatively, the target protein (i.e. Flt3 ligand) was inserted in GPMAW (Lighthouse Data, Odense, Denmark) and analyzed with regard to the obtained peptide masses.
Glycosylation analysis of Isokine FLT3 ligand
Glycosylation of FLT3 ligand was analyzed by specific antibodies to α-1,3-fucose (AS07 268 Agrisera, Vännäs, Sweden) and β-1,2-xylose (AS07 267 Agrisera). Two hundred fifty nanogram of Isokine Flt3 ligand and commercially available E. coli produced recombinant Flt3 ligand were loaded on a SDS-PAGE gel. Immunoblotting was performed as described above.
Biological assay in cultures of hematopoietic precusors
The biological activity of ISOkine Technical University of Denmark), respectively. Glycosylation at one or more of these sites in the protein would affect its mobility on the gel, explaining the higher molecular weight protein bands observed on the gel. Furthermore, heterogeneous glycosylation has been observed for expressed growth factors in other plant systems like tobacco [16] and rice seeds [17] . In contrast, E. coli produced Flt3 ligand presents a single band in a Coomassie brilliant blue-stained SDS-PAGE (Fig. 2- A, Lane 3) as well as in western blot analysis with anti-Flt3 ligand antibodies. In addition, a larger band around 60 kDa is observed ( Fig.   2 -B, Lane 1). Analysis of the glycosylation of Isokine Flt3 ligand, using specific antibodies, demonstrated that the Isokine Flt3 ligand contains α-1,3-fucose and α-1,2-xylose derivatives (Fig. 2-C,-D) . The E. coli produced recombinant Flt3 ligand showed no reactivity to these antibodies as expected. It has been shown that glycosylation is an important element of many growth factors and cytokines which can enhance their activity and/or stability in biological systems [18] .
Barley produced Flt3 ligand is biologically active 16 The and NK-cell growth and differentiation was supported by IL-7 and IL-15, respectively [22, 25] . A dose dependant increase in cell numbers was observed with the addition of Flt3 ligand (Fig. 3-D ligand. 18 The biological activity of purified ISOkine Flt3 ligand from transgenic barley seeds was also determined with cell proliferation assay using AML5 cells that require Flt3 ligand for normal growth. The protein was found to be biologically active with an ED 50 of 0.15 ng/ml and a calculated net OD 450 for ED 50 0.518 and maximum cell density level of OD 450 1.06 (Fig. 4) 
Concluding remarks
In this study, we have demonstrated for the first time a high expression of biologically active Flt3 ligand in a plant system. The growth factor was specifically expressed in barley seeds-a strategy that presents many advantages such as self containment, ease of processing and storage as well as a relatively simple protein profile. 
